Warning letter
TYA Pharmaceuticals: warning letter of Aug 6, 2002
FDA warning letter UCM145044 · Florida District Office
Key facts
| Reference number | UCM145044 |
|---|---|
| Company | TYA Pharmaceuticals |
| Subject | CGMP for Finished Pharmaceuticals/CGMP in Manufacturing, Processing, Packing, or Holding/Adulterated |
| Issue date | Aug 6, 2002 |
| Posted date | Aug 6, 2002 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 211.63, 211.25, 211.198, 211.180, 211.150, 211.137, 211.110 |
| Country | 3 |
| Inspection city | Tallahassee |
| Inspection ZIP | 32301-3534 |
| Inspection start date | Feb 11, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: